law: Drugs and Cosmetics Act, 1940
  33. Power of Central Government to make rules
   137  [(1) The Central Government may 138[after
  
  consultation with, or on the recommendation of, the Board] and after previous
  
  publication by notification in the Official Gazette, make rules for the purpose
  
  of giving effect to the provisions of this Chapter:
  Provided that consultation with the Board may be
  
  dispensed with if the Central Government is of opinion that circumstances have
  
  arisen which render it necessary to make rules without such consultation, but
  
  in such a case the Board shall be consulted within six months of the making of
  
  the rules and the Central Government shall take into consideration any
  
  suggestions which the Board may make in relation to the amendment of the said
  
  rules.]
  (2) Without prejudice to the generality of the foregoing power,
  
  such rules may-
  (a) provide for the establishment of
  
  laboratories for testing and analyzing drugs 139[or cosmetics];
  (b) prescribe the qualifications and duties of
  
  Government Analysts and the qualifications of Inspectors;
  (c) prescribe the methods of test or analysis
  
  to be employed in determining whether a drug 139[or cosmetic] is of
  
  standard quality;
  (d) prescribe, in respect of biological and
  
  organometallic compounds, the units or methods of standardization;
   140  [(dd) prescribe under clause (d) of 141[section
  
  17A] the colour or colors which a drug may bear or contain for purposes of
  
  coloring;]
  (e) prescribe the forms of licenses 142[for the
  
  manufacture for sale or for distribution], for the sale and for the
  
  distribution of drugs or any specified drug or class of drugs 139[or
  
  of cosmetics or any specified cosmetic or class of cosmetics], the form of
  
  application for such licenses, the conditions subject to which such licenses
  
  may be issued, the authority empowered to issue the same 143[the
  
  qualifications of such authority] and the fees payable therefor; 143[and
  
  provide for the cancellation or suspension of such licenses in any case where
  
  any provision of this Chapter or the rules made thereunder is contravened or
  
  any of the conditions subject to which they are issued is not complied with];
   144  [(ee) prescribe the records, registers or other documents
  
  to be kept and maintained under section 18B ;
  (eea) prescribe the fees for the inspection (for the purposes of
  
  grant or renewal of licenses) of premises, wherein any drug or cosmetic is
  
  being or is proposed to be manufactured ;
  (eeb) prescribe the manner in which copies are to be certified
  
  under sub-section (2A) of section 22;]
  (f) specify the diseases or ailments which a drug may not
  
  purport or claim 145[to prevent, cure or mitigate] and such other
  
  effects which a drug may not purport or claim to have;
  (g) prescribe the conditions subject to which small quantities
  
  of drugs may be manufactured for the purpose of examination, test or analysis ;
  (h) require the date of manufacture and the date of expiry of
  
  potency to be clearly and truly stated on the label or container of any
  
  specified drug or class of drugs, and prohibit the sale, stocking or exhibition
  
  for sale, or distribution of the said drug or class of drugs after the expiry
  
  of a specified period from the date of manufacture or after the expiry of the
  
  date of potency;
  (i) prescribe the conditions to be observed in the packing in bottles,
  
  packages, and other containers of drugs 146[or cosmetics], 144[including
  
  the use of packing material which comes into direct contact with the drugs] and
  
  prohibit the sale, stocking or exhibition for sale, or distribution of drugs 146[or
  
  cosmetics] packed in contravention of .such conditions;
  (j) regulate the mode of labeling packed drugs 146[or
  
  cosmetics], and prescribe the matters which shall or shall not be included in
  
  such labels;
  (k) prescribe the maximum proportion of any poisonous substance
  
  which may be added to or contained in any drug, prohibit the manufacture, sale
  
  or stocking or exhibition for sale, or distribution of any drug in which that
  
  proportion is exceeded, and specify substances which shall be deemed to be
  
  poisonous for the purposes of this Chapter and the rules made thereunder;
  (l) require that the accepted scientific name of any specified
  
  drug shall be displayed in the prescribed manner on the label or wrapper of any
  
  patent or proprietary medicine containing such drug ;
   147  [***]
   148  [(n) prescribe the powers and duties of Inspectors 144[and
  
  the qualifications of the authority to which such Inspectors shall be
  
  subordinate] and 149[specify the drugs or classes of drugs or
  
  cosmetics or classes of cosmetics] in relation to which and the conditions,
  
  limitations or restrictions subject to which, such powers and duties may be
  
  exercised or performed;]
  (o) prescribe the forms of report to be given by Government
  
  Analysts, and the manner of application for test or analysis under section 26
  
  and the fees payable therefor ;
   150  [(p) specify the offences against this Chapter or any rule
  
  made thereunder in relation to which an order of confiscation may be made under
  
  section 31 and]
  (q) provide for the exemption, conditionally or otherwise, from
  
  all or any of the provisions of this Chapter or the rules made thereunder, of
  
  any specified drug or class of drugs 146[or cosmetic or class of
  
  cosmetics].